Proteasome inhibitor for treatment of multiple myeloma
Document Type
Article
Department
Ophthalmology
Abstract
Bortezomib is more effective than high-dose dexamethasone for treatment of patients with relapsed multiple myeloma, according to results from the Assessment of Proteasome Inhibition for Extending Remissions
Publication (Name of Journal)
lancet oncology
Recommended Citation
Ahmed, K.
(2005). Proteasome inhibitor for treatment of multiple myeloma. lancet oncology, 6(8), 546.
Available at:
https://ecommons.aku.edu/pakistan_fhs_mc_surg_surg/426
COinS